Loading article...
Pharmacists warn of worsening drug shortages for diabetes and Parkinson's patients as Iran blockade disrupts supply chains
The Independent Pharmacists Association has warned that shortages of several vital drugs for type two diabetes and Parkinson's disease have worsened significantly due to Iran's blockade of the Strait of Hormuz disrupting global pharmaceutical supply chains.
The Independent Pharmacists Association has issued a warning that shortages of several vital medications, including drugs for type two diabetes and Parkinson's disease, have worsened significantly as a result of Iran's blockade of the Strait of Hormuz disrupting global pharmaceutical supply chains.
Pharmacists across the United Kingdom report increasing difficulty in sourcing essential medications for patients who depend on them daily. The shortages extend beyond common drugs to include specialist treatments that have limited alternative formulations available.
The disruption to the Strait of Hormuz, through which a significant portion of global trade passes, has had far-reaching consequences beyond the energy sector. Pharmaceutical raw materials and finished products that transit through the region have been caught up in the broader supply chain crisis caused by the ongoing conflict.
Patients with chronic conditions are among the most vulnerable, as gaps in medication supply can have serious health consequences. Pharmacists are working to source alternatives where possible, but warn that some drugs simply have no readily available substitutes.
The warning highlights a lesser-discussed impact of the Iran conflict on everyday life in countries far removed from the fighting. Health professionals are calling on the government to take urgent action to secure pharmaceutical supply routes and ensure that patients do not suffer as a result of geopolitical disruption.